1. Screening Libraries
  2. Kinase Inhibitor Library

Kinase Inhibitor Library

Cat. No.: HY-L009
Library Contents: XLSX PDF

A unique collection of 848 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

Kinase Inhibitor Library
Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 848 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

•   The library contains compounds targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.) and carbohydrate kinases (Hexokinase).

•   Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   Rich documentation with structure, IC50, and customer reviews.

•   NMR and HPLC validated to ensure high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 848 kinase inhibitors/regulators supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Kinase Inhibitor Library

Source: MedChem Express

Contents of Kinase Inhibitor Library

Plate layout: HY-L009-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty MRT68921 (hydrochloride) AZD0156 LY3177833 NT157 Flavopiridol Flavopiridol (Hydrochloride) SNS-032 TA-01 AZD-5438 GSK'481 Empty
b Empty R547 EAI045 AM-2394 IQ-1 GSK583 NVP-BAW2881 PF-04979064 MLi-2 WYE-132 AEE788 Empty
c Empty GSK2256098 Tyrphostin AG 528 NPS-1034 RAF709 NVS-PAK1-1 MSDC 0160 (E)-Necrosulfonamide NH125 APS-2-79 Y-33075 Empty
d Empty LM22A-4 Y-27632 IPI549 TPCA-1 PF-06651600 SAR-20347 CEP-40783 HA-100 RIPA-56 Src Inhibitor 1 Empty
e Empty LY294002 AS-605240 IC-87114 TG100-115 TP-3654 TGX-221 PI-103 PI-103 (Hydrochloride) ZINC00881524 Barasertib-HQPA Empty
f Empty AZD1152 GDC-0326 ZM-447439 PD-166866 RG14620 RG13022 ISCK03 SUN11602 BAY-1895344 (hydrochloride) M3814 Empty
g Empty Nilotinib Nilotinib (monohydrochloride monohydrate) Tozasertib MSC2530818 LTURM34 IMD-0354 Btk inhibitor 2 PHA-680632 Danusertib MLN8054 Empty
h Empty Dasatinib Dasatinib (hydrochloride) CHIR-99021 CHIR-99021 (monohydrochloride) GSK'872 Linsitinib NVP-TAE 684 LYN-1604 hydrochloride AZD-1480 BTK IN-1 Empty

Plate layout: HY-L009-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SMI-16a Wortmannin BMS-754807 Sorafenib Sorafenib (Tosylate) Tandutinib OSI-930 Cediranib Amuvatinib Dovitinib (lactate) Empty
b Empty Pazopanib Masitinib Masitinib (mesylate) CUDC-101 Motesanib Motesanib (Diphosphate) Saracatinib BRAF inhibitor RAF265 GSK-690693 Empty
c Empty NVP-ADW742 AG1024 PD0325901 Sunitinib SB 203580 Vandetanib Afatinib Afatinib (dimaleate) BMS-536924 SB 202190 Empty
d Empty Omipalisib LY3200882 Repotrectinib PIK-294 ABT-702 dihydrochloride Doramapimod PD173074 Falnidamol D4476 CL-387785 Empty
e Empty GW788388 Neflamapimod JNJ-7706621 Regorafenib Regorafenib (monohydrate) Brivanib (alaninate) Brivanib Foretinib KW-2449 KX2-391 (dihydrochloride) Empty
f Empty KX2-391 (Mesylate) Fasudil (Hydrochloride) Enzastaurin Sotrastaurin AZD 6482 AKT inhibitor VIII MK 2206 (dihydrochloride) THZ531 BI-78D3 Canertinib (dihydrochloride) Empty
g Empty PF-06409577 Pim1/AKK1-IN-1 PP121 Semaxinib PD173955 VX-702 Losmapimod PH-797804 Talmapimod SU 5402 Empty
h Empty Fedratinib TG101209 AZD-8055 OSI-027 Milciclib SB-431542 A 83-01 sodium salt TAK-715 PF-562271 (besylate) PF-562271 Empty

Plate layout: HY-L009-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty PF-573228 Torkinib Dinaciclib BMS-794833 SU14813 SU14813 (maleate) BI-D1870 AR-A014418 BX795 Orantinib Empty
b Empty BMS-345541 BMS-345541 (free base) CGP 57380 GSK1904529A Telatinib ARRY-380 (analog ) GW 5074 CYC-116 PD 169316 Pluripotin Empty
c Empty GSK 3 Inhibitor IX Y-27632 (dihydrochloride) TWS119 Ro 28-1675 Ningetinib Tosylate Ningetinib 6-Bromo-2-hydroxy-3-methoxybenzaldehyde 2-Phospho-L-ascorbic acid trisodium salt EG00229 CCT 137690 Empty
d Empty AG126 LRRK2-IN-1 Lazertinib GW2580 GNF-7 FLT3-IN-1 Momelotinib Momelotinib sulfate SB-590885 Alisertib Empty
e Empty Tivozanib Lenvatinib ENMD-2076 (Tartrate) ENMD-2076 MGCD-265 analog AZD-7762 Adavosertib Ibrutinib Trametinib Trametinib (DMSO solvate) Empty
f Empty GSK429286A PHA-793887 CP-466722 GW843682X AZ 628 BX-912 KU-57788 GNF-2 CGP60474 A-484954 Empty
g Empty TDZD-8 WHI-P97 SB 239063 Pilaralisib analogue Nintedanib esylate PHA-665752 R406 (free base) CZC-8004 LX2343 SEL120-34A (monohydrochloride) Empty
h Empty SM 16 eCF506 SLV-2436 BMS-986195 GDC-0575 ARQ 531 O-304 AZ32 SJ000291942 ETC-206 Empty

Plate layout: HY-L009-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty CC-90003 MBQ-167 IITZ-01 PF-05231023 2-D08 CGI-1746 AG-490 WZ-3146 SNS-314 Erlotinib (Hydrochloride) Empty
b Empty Pazopanib (Hydrochloride) BMS-599626 (Hydrochloride) PD153035 (Hydrochloride) SU11274 KU-55933 PF-04217903 PF-04217903 (methanesulfonate) Vatalanib (dihydrochloride) SGX-523 WZ4002 Empty
c Empty PD98059 U0126 WYE-354 AMG-208 GSK1059615 Rigosertib (sodium) Ki8751 Lyn-IN-1 SP600125 Pimasertib Empty
d Empty SB 525334 Cabozantinib (S-malate) HMN-214 PIK-93 Ponatinib Chelerythrine Chloride CCT129202 CP-673451 Hesperadin BIX02188 Empty
e Empty BIX02189 Vemurafenib AZD8330 AT7867 AT7867 (dihydrochloride) KRN-633 KU-60019 PD318088 PHT-427 R406 Empty
f Empty PI3K-IN-1 DPH LDN193189 (Hydrochloride) Lck Inhibitor BMS 777607 Poloxin Volasertib Lorlatinib PI-3065 CID755673 Empty
g Empty DMH-1 ML347 FR 180204 AZ191 K02288 Umbralisib Serabelisib Defactinib Defactinib (hydrochloride) IM-12 Empty
h Empty WH-4-023 CFI-400945 (free base) CFI-400945 (fumarate) Kenpaullone AZD8186 KRCA-0008 HTH-01-015 UNC2025 UNC2025 (hydrochloride) ETC-1002 Empty

Plate layout: HY-L009-5

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Gilteritinib Y15 Decernotinib PF-4800567 PF-06447475 SAR405 LY-2584702 (tosylate salt) LDC1267 ISRIB (trans-isomer) ANA-12 Empty
b Empty SKF-86002 LY3023414 Bikinin Ro-3306 LY3009120 ZM39923 (hydrochloride) URMC-099 ON123300 Acalisib LDC4297 Empty
c Empty Entrectinib ITD-1 GNE-317 BLZ945 IC261 L-779450 Vps34-PIK-III Vps34-IN-1 BLU9931 Mirk-IN-1 Empty
d Empty CCT196969 BAY1217389 Larotrectinib sulfate Bimiralisib AZD-8835 AMG319 R-268712 TP-0903 SGI-7079 S49076 Empty
e Empty PRT-060318 Quizartinib Torin 2 PF-3758309 Alectinib Alectinib Hydrochloride RepSox Cabozantinib MRT67307 GSK1838705A Empty
f Empty CC-401 (hydrochloride) Rebastinib Idelalisib Gandotinib Fostamatinib Disodium Fostamatinib disodium hexahydrate Cediranib (maleate) Sapitinib ACHP (Hydrochloride) Cobimetinib Empty
g Empty Cobimetinib (hemifumarate) Golvatinib CHIR-98014 NVP-TAE 226 Crenolanib Galunisertib SD-208 YM-201636 CDK9-IN-1 GSK2578215A Empty
h Empty Ralimetinib dimesylate Apitolisib MK-5108 AMG 900 Desmethyl Erlotinib Thiazovivin NVP-BHG712 CCT128930 A66 CHIR-124 Empty

Plate layout: HY-L009-6

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Degrasyn BS-181 Dacomitinib IRAK inhibitor 1 IRAK inhibitor 2 IRAK inhibitor 3 IRAK inhibitor 6 PIK-75 SGI-1776 KN-62 Empty
b Empty Mps1-IN-1 SR-3677 LY2874455 Regorafenib (Hydrochloride) Infigratinib JNK-IN-8 ASP3026 Sapanisertib IRAK-1-4 Inhibitor I AZD4547 Empty
c Empty NVP-BGT226 Apatinib Capmatinib AICAR AICAR (phosphate) Dorsomorphin (dihydrochloride) Deguelin TAK-733 CID 2011756 PHA-767491 (hydrochloride) Empty
d Empty LY-364947 ALK-IN-1 HG-10-102-01 GNF-5837 Mubritinib Mitoxantrone Mitoxantrone (dihydrochloride) Piceatannol Nocodazole SB-505124 Empty
e Empty Fimepinostat AG-1478 CAY10505 AS-252424 BPR1J-097 Hydrochloride AZM475271 Oclacitinib (maleate) Chrysophanol Miltefosine PQ401 Empty
f Empty IKK 16 Go 6983 Oglufanide R1530 Valrubicin ZM 306416 SC-514 PP1 MK-8745 GSK2656157 Empty
g Empty SKI II PLX647 BX517 PF-4989216 Ro 31-8220 (mesylate) WHI-P154 PD168393 CNX-2006 Taselisib Berzosertib Empty
h Empty Flumatinib Flumatinib (mesylate) TCS 359 Hydroxyfasudil Hydroxyfasudil (hydrochloride) PND-1186 PD0166285 1-Naphthyl PP1 1-Naphthyl PP1 (hydrochloride) 1-NM-PP1 Empty

Plate layout: HY-L009-7

1 2 3 4 5 6 7 8 9 10 11 12
a Empty CNX-774 BML-277 SRPIN340 2-Deoxy-D-glucose DDR1-IN-1 Mps1-IN-2 B-Raf inhibitor 1 VX-11e PD153035 Emodin Empty
b Empty TBB MP7 XMD8-92 PF-03814735 Palomid 529 Genistein [6]-Gingerol Dabrafenib Dabrafenib (Mesylate) CP-724714 Empty
c Empty Refametinib AZ3146 Reversine CCT241533 (hydrochloride) Rabusertib Tepotinib NVP-BSK805 (dihydrochloride) VE-821 Bentamapimod Tideglusib Empty
d Empty GSK2334470 BAY 61-3606 (dihydrochloride) AST 487 5-Aminosalicylic Acid NG 52 MLN0905 SBE13 (Hydrochloride) TAK-960 TAK-960 (dihydrochloride) Icotinib (Hydrochloride) Empty
e Empty Icotinib SB1317 Dactolisib (Tosylate) PF-04691502 Buparlisib (Hydrochloride) Ipatasertib Ipatasertib dihydrochloride GSK 650394 EMD638683 TAK-285 Empty
f Empty Agerafenib Binimetinib CHR-6494 c-Kit-IN-1 NVP-LCQ195 Alpelisib GSK2636771 TAK-580 Vistusertib GDC-0349 Empty
g Empty BMS-911543 BMS-265246 AIM-100 CZC24832 SLx-2119 WP1066 Baricitinib Baricitinib (phosphate) PRT062607 (Hydrochloride) AG 555 Empty
h Empty CVT-313 CEP-33779 BIO-acetoxime ALK inhibitor 2 5-Iodotubercidin Capivasertib SL327 SB 415286 NVP-BVU972 Triciribine Empty

Plate layout: HY-L009-8

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SAR131675 Imatinib CH5132799 ZM323881 (hydrochloride) MLN120B TTP 22 PF-670462 Picropodophyllin JANEX-1 Tyrphostin A9 Empty
b Empty TC-DAPK 6 Merestinib CGK733 ETP-46464 kb NB 142-70 DMAT FRAX486 GSK269962A AZ20 SSR128129E Empty
c Empty AZD1208 AZD-3463 GDC-0623 TIC10 Tyrphostin 23 Ceritinib Ceritinib dihydrochloride IPA-3 XMD17-109 GZD824 Empty
d Empty SAR407899 (hydrochloride) SAR407899 CRT0066101 dihydrochloride LH846 NU 7026 Afuresertib Afuresertib (hydrochloride) Rociletinib Rociletinib hydrobromide Poziotinib Empty
e Empty GNF-5 XL228 RKI-1447 Necrostatin-1 AZD2858 A 419259 (trihydrochloride) TAK-632 Tirabrutinib Osimertinib PF-4708671 Empty
f Empty Ribociclib Ribociclib hydrochloride Ribociclib succinate Ribociclib succinate hydrate K145 (hydrochloride) UNC2250 UNC2881 CZC-25146 WZ4003 Ulixertinib Empty
g Empty NMS-1286937 SAR-260301 ID-8 CEP-37440 STF-083010 HS-173 LDC000067 TCS JNK 5a AMG 925 (HCl) LDN-212854 Empty
h Empty Voxtalisib ML167 Uprosertib Entospletinib H-89 (dihydrochloride) APY0201 Cerdulatinib Tucatinib AT13148 AZD7545 Empty

Plate layout: HY-L009-9

1 2 3 4 5 6 7 8 9 10 11 12
a Empty JI-101 LY2090314 Abemaciclib (methanesulfonate) Pacritinib Phenformin (hydrochloride) Pilaralisib Butein Resveratrol TCS-PIM-1-4a VS-5584 Empty
b Empty CNX-1351 ZLN024 (hydrochloride) LDN-214117 Acumapimod Pexidartinib Solcitinib Pexmetinib JH-II-127 CC-223 Sitravatinib Empty
c Empty CC-115 CC-115 (hydrochloride) Duvelisib Duvelisib (R enantiomer) Metformin (hydrochloride) APY29 Acalabrutinib Alofanib Belizatinib PS-1145 Empty
d Empty LFM-A13 Spebrutinib CEP-28122 (mesylate salt) GSK2606414 Quercetin TCS PIM-1 1 CX-6258 CX-6258 (hydrochloride hydrate) CCT241736 GNE-7915 Empty
e Empty GNE-7915 (tosylate) Prexasertib Prexasertib (dihydrochloride) AZD2932 Purvalanol B Purvalanol A Filgotinib BMS-3 BMS-5 GW 441756 Empty
f Empty FIIN-2 PD158780 SU9516 Ro 5126766 Centrinone Centrinone-B AMG-337 Erdafitinib SCR-1481B1 BQR-695 Empty
g Empty SC79 AZD3759 WEHI-345 ONO-4059 (analog) BI-847325 CCT245737 CHZ868 TAS-301 PLX8394 GSK180736A Empty
h Empty 3-Methyladenine NU2058 Ceralasertib Compound 401 T56-LIMKi Peficitinib NVP-ACC789 MCB-613 Tauroursodeoxycholate (Sodium) trans-Zeatin Empty

Plate layout: HY-L009-10

1 2 3 4 5 6 7 8 9 10 11 12
a Empty 4μ8C LJH685 LJI308 Olmutinib STO-609 Indirubin-3'-monoxime EGFR-IN-3 Avitinib (maleate) SC66 Fenebrutinib Empty
b Empty PF06650833 Fruquintinib Vactosertib Vactosertib (Hydrochloride) CH5183284 YU238259 PF-06459988 3-Bromopyruvic acid Pictilisib (dimethanesulfonate) Tyrphostin AG 879 Empty
c Empty Seliciclib Pelitinib Neratinib Tofacitinib Tofacitinib (citrate) Pictilisib CI-1040 AT9283 A-769662 JNJ-38877605 Empty
d Empty Tivantinib BI 2536 Selumetinib KU-0063794 Linifanib Palbociclib (hydrochloride) ZSTK474 Silmitasertib Silmitasertib (sodium salt) Ruxolitinib Empty
e Empty Ruxolitinib (phosphate) GDC-0879 Bafetinib GSK461364 Crizotinib Crizotinib (hydrochloride) Gefitinib Gefitinib (hydrochloride) Erlotinib Lapatinib Empty
f Empty Lapatinib (ditosylate) Nintedanib Dovitinib Perifosine Temsirolimus AT7519 AT7519 (Hydrochloride) Imatinib (Mesylate) PLX-4720 Tolimidone Empty
g Empty GSK-1070916 Aurora A inhibitor I Buparlisib Poloxime MNS A 77-01 THZ1 THZ1 (Hydrochloride) Palbociclib (isethionate) Lonidamine Empty
h Empty Methylthiouracil Amlexanox Bucladesine (sodium salt) Bucladesine (calcium salt) LY2409881 SU6656 Altiratinib CZC-54252 AZ-5104 MHY1485 Empty

Plate layout: HY-L009-11

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Danthron Trapidil Flufenamic acid Chloropyramine hydrochloride Metadoxine Honokiol Oridonin Verbascoside Ginsenoside Rb1 Ginsenoside Re Empty
b Empty Ferulic acid Salidroside Dihydromyricetin Neohesperidin dihydrochalcone Formononetin Atractylenolide I Bakuchiol Pachymic acid Wogonin Cucurbitacin E Empty
c Empty Quercitrin Astragaloside IV L-Leucine Corynoxeine Carnosol Dicoumarol Dehydrocorydaline (chloride) Harmine Scutellarin Scutellarein Empty
d Empty Isovitexin Isorhamnetin Ginkgolide C Ingenol Magnolin 1,3-Dicaffeoylquinic acid Loureirin B Loureirin A 3,4-Dimethoxycinnamic acid Hispidulin Empty
e Empty Piperlongumine Palmitelaidic Acid 7-Hydroxy-4H-chromen-4-one 7-Methoxyisoflavone Protein kinase inhibitors 1 hydrochloride 2,5-Dihydroxybenzoic acid Skatole Ferulic acid methyl ester Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Kinase Inhibitor Library
Cat. No.:
HY-L009
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.